
Structure-based Ligand Design
Wiley-VCH (Publisher)
Published on 20. April 1998
Book
Hardback
XIV, 167 pages
978-3-527-29343-8 (ISBN)
Article exhausted; check different version
Description
Although emerging only since the 1980s, structure-based drug design has already become a powerful tool for commercial drug design. Much has been learned, however, since the first attempts to develop drugs on the basis of available biochemical and structural data. This volume, besides presenting the underlying principles and foundations of the approach, describes real-life applications. It shows that structure-based drug design, if employed properly and with a thorough knowledge of the pitfalls to avoid, is superior to the traditional approach of designing new drugs and can thus save large amounts of time and money. The presentation and many references to the original literature, as well as numerous colour figures illustrating structural relationships, should make this volume a tool for scientists working in the area of drug design.
More details
Series
Language
English
Place of publication
Weinheim
Germany
Target group
Professional and scholarly
Illustrations
ca. 80 farb. Abb.
Dimensions
Height: 24 cm
Width: 17 cm
Weight
540 gr
ISBN-13
978-3-527-29343-8 (9783527293438)
Schweitzer Classification
Other editions
Additional editions

Klaus Gubernator | Hans-Joachim Böhm
Structure-based Ligand Design
E-Book
11/2008
1st Edition
Wiley-VCH
€124.99
Available for download
Content
Structural biochemistry; sources of structural information; classes of therapeutic targets; possible approaches to structure-based ligand design; inhibition of proteases; inhibition of sialidase; design methodologies and their applications; automated receptor-based de novo ligand design; empirical methods for binding energy prediction.